COMBINATION THERAPY IN STAGE-C AND STAGE-D PROSTATIC-CANCER - RATIONALE AND 5-YEAR CLINICAL-EXPERIENCE

被引：2
|
作者：
LABRIE, F
DUPONT, A
BELANGER, A
CUSAN, L
GIGUERE, M
LACOURCIERE, Y
LUTHY, I
BEGIN, D
LABRIE, C
SIMARD, J
MONFETTE, G
EMOND, J
机构：
[1] UNIV LAVAL, MED CTR, DEPT MED, QUEBEC CITY G1V 4G2, QUEBEC, CANADA
[2] UNIV LAVAL, MED CTR, DEPT NUCL MED, QUEBEC CITY G1V 4G2, QUEBEC, CANADA
[3] HOTEL DIEU, DEPT UROL, ST JEROME, QUEBEC, CANADA
[4] HOTEL DIEU, DEPT UROL, LEVIS, QUEBEC, CANADA
来源：
CANCER AND METASTASIS REVIEWS | 1987年 / 6卷 / 04期
关键词：
D O I：
10.1007/BF00047470
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：615 / 636
页数：22
相关论文
共 50 条
  • [31] COMBINATION THERAPY WITH AN LHRH AGONIST AND FLUTAMIDE AT VARIOUS STAGES OF PROSTATE-CANCER - 7-YEAR CLINICAL-EXPERIENCE
    LABRIE, F
    DUPONT, A
    CUSAN, L
    EMOND, J
    MONFETTE, G
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 151 - 151
  • [32] 20 YEAR FOLLOW-UP RESULTS OF PATIENTS WITH SURGICALLY INCURABLE PROSTATIC-CANCER (STAGE-C-T3T4)
    DELREGATO, JA
    TRALINS, AH
    PITTMAN, DD
    ANNALES D UROLOGIE, 1994, 28 (04) : 238 - 240
  • [33] COMBINATION THERAPY WITH FLUTAMIDE AND MEDICAL (LHRH AGONIST) OR SURGICAL CASTRATION IN ADVANCED PROSTATE-CANCER - 7-YEAR CLINICAL-EXPERIENCE
    LABRIE, F
    DUPONT, A
    CUSAN, L
    GOMEZ, J
    EMOND, J
    MONFETTE, G
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (06): : 943 - 950
  • [34] Value of pretreatment automated hemogram as a 5-year survival predictor in uterine cervical cancer clinical stage IIB-IVA
    Isabel Luna-Abanto, Luciana
    Fermin Yan-Quiroz, Edgar
    REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2021, 14 (01): : 40 - 47
  • [35] A PHASE-II EVALUATION OF A 3-DRUG COMBINATION OF CYCLOPHOSPHAMIDE, DOXORUBICIN AND 5-FLUOROURACIL AND OF 5-FLUOROURACIL IN PATIENTS WITH ADVANCED BLADDER-CARCINOMA OR STAGE-D PROSTATIC-CARCINOMA
    SMALLEY, RV
    BARTOLUCCI, AA
    HEMSTREET, G
    HESTER, M
    JOURNAL OF UROLOGY, 1981, 125 (02): : 191 - 195
  • [36] CONSERVATIVE SURGERY WITH RADIATION-THERAPY IN CLINICAL STAGE-I AND STAGE-II BREAST-CANCER - RESULTS OF A 20-YEAR EXPERIENCE
    HAFFTY, BG
    GOLDBERG, NB
    ROSE, M
    HEIL, B
    FISCHER, D
    BEINFIELD, M
    MCKHANN, C
    WEISSBERG, JB
    ARCHIVES OF SURGERY, 1989, 124 (11) : 1266 - 1270
  • [37] INTEGRATION OF SAFE INITIAL COMBINATION CHEMOTHERAPY (WITHOUT CISPLATIN) WITH A HIGH RESPONSE RATE AND LOCAL THERAPY FOR UNTREATED STAGE-III AND STAGE-IV EPIDERMOID CANCER OF THE HEAD AND NECK - 5-YEAR SURVIVAL-DATA
    PRICE, LA
    MACRAE, K
    HILL, BT
    CANCER TREATMENT REPORTS, 1983, 67 (06): : 535 - 539
  • [38] ADJUVANT ENDOCRINE THERAPY, CYTO-TOXIC CHEMOTHERAPY, AND IMMUNOTHERAPY IN STAGE-II BREAST-CANCER - 5-YEAR RESULTS
    PEARSON, OH
    HUBAY, CA
    MARSHALL, JS
    GORDON, NH
    MCGUIRE, WL
    MANSOUR, EG
    HERMANN, RE
    JONES, JC
    FLYNN, WJ
    ECKERT, C
    BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 : S61 - S68
  • [39] Lung cancer in octogenarians. Retrospective study of clinical characteristics and therapy in a single-center and a 5-year experience.
    Ortega Granados, Ana Laura
    Quesada, Nuria Cardenas
    Garrido, Carmen Rosa
    Sanjuan, Maria Ruiz
    Fernandez-Navarro, Monica
    Fernandez, Yessica Plata
    Caro, Natalia Luque
    Garcia Verdejo, Francisco Jose
    Leiva, Pedro Lopez
    Moreno Jimenez, Miguel Angel
    Ortega, Esther Martinez
    Morago, Ana Jaen
    Garcia, Rosario Duenas
    Cebrian, Irene Gonzalez
    Ales-Martinez, Jose
    Rovira, Pedro Sanchez
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Computed tomography-guided frameless stereotactic radiotherapy for Stage I non-small-cell lung cancer: A 5-year experience
    Uematsu, M
    Shioda, A
    Suda, A
    Fukui, T
    Ozeki, Y
    Hama, Y
    Wong, JR
    Kusano, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03): : 666 - 670
12345